The 13th edition of the European Biotechnology Science & Industry Guide is showcasing brilliant science and excellent business from companies, universities, research institutes, and expert support providers. In addition to the detailed portraits on approx. 188 colored pages, the guide features a report about sustainibility and the biologisation of industrial production. Readers will discover many success stories and current trends in the European biotech industry.
Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals
Latest NewsAntisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
Hot of the press: new issue of BIOTECH Insight
Latest NewsThe latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.
Macomics licences macrophage modulator to Ono
Latest NewsEdinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.
mbiomics GmbH cashes in €13m in Series A financing
Latest NewsMunich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital.
Neogap Therapeutics appoints CMO
AppointmentsSwedish Neogap Therapeutics got a new Chief Medical Officer (CMO). Dr Hanjing Xie has recently started her new position at the Stockholm-based biotech company.
BioIVT | Human AB Serum – Plasma-derived
ProductsSerum-supplemented cell culture media remains the gold standard for obtaining near in vivo conditions. That’s why we have expanded our product line to include GMP-grade Human AB Serum.
How the German capital region supports founders
BackgroundThe Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to keep it that way: with a wide variety of space offerings and support programs for founders and start-ups.
Biotech funding environment calls for more creativity
OpinionFrom its all-time high in August 2021 the largest and most important index for the biotech industry also in Europe (NBI) lost around 25%. After a period of excessive capital inflows, money is much harder to come by these days. The answer can only be more creativity in structuring deals.
13th European Biotechnology Guide 2023
ProductsThe 13th edition of the European Biotechnology Science & Industry Guide is showcasing brilliant science and excellent business from companies, universities, research institutes, and expert support providers. In addition to the detailed portraits on approx. 188 colored pages, the guide features a report about sustainibility and the biologisation of industrial production. Readers will discover many success stories and current trends in the European biotech industry.
Upscaling AAV gene therapy
Latest NewsBiovian Oy’s second generation AAV platform will include Remedium Bio Inc.’s lead treatment candidate against Osteoarthritis.